Status: Recruiting
Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer
phase II clinical trial to evaluate node-sparing short-course radiation combined with total neoadjuvant CAPOX and Sintilimab for MSS locally advanced rectal cancers.
Participants needed: 37
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Jinhua Central HospitalUpdated: Apr 24, 2026Locations: 1
Eligibility criteria
Patients who have a strong willingness to preserve the anus and are willing to r... [+7]
Patients with a previous history of malignant tumors besides rectal cancer. [+11]